Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Medical Specialties
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MDT | Medtronic PLC | -0.30% | 96.59 | 0.6% | $490.04m | |
| ABT | Abbott Laboratories | 0.21% | 68.56 | 0.8% | $297.97m | |
| ISRG | Intuitive Surgical, Inc. | -1.82% | 554.57 | 2.4% | $251.17m | |
| TMO | Thermo Fisher Scientific Inc. | 0.46% | 240.20 | 1.0% | $247.20m | |
| ALGN | Align Technology, Inc. | -0.38% | 384.50 | 6.3% | $227.34m | |
| BAX | Baxter International Inc. | 0.14% | 77.35 | 1.7% | $207.35m | |
| BDX | Becton, Dickinson and Company | -0.05% | 259.62 | 1.1% | $207.03m | |
| BSX | Boston Scientific Corporation | -0.86% | 37.30 | 1.1% | $205.99m | |
| SYK | Stryker Corporation | -0.82% | 172.67 | 1.3% | $176.11m | |
| ABMD | ABIOMED, Inc. | -1.61% | 370.49 | 3.3% | $168.72m | |
| TNDM | Tandem Diabetes Care, Inc. | -4.16% | 40.60 | 4.1% | $159.53m | |
| EW | Edwards Lifesciences Corporation | 0.97% | 147.37 | 1.2% | $133.63m | |
| DXCM | DexCom, Inc. | -1.62% | 137.06 | 8.5% | $127.23m | |
| ZBH | Zimmer Biomet Holdings, Inc. | -0.19% | 130.20 | 1.7% | $126.64m | |
| XRAY | DENTSPLY International Inc. | 1.47% | 38.75 | 3.0% | $105.19m |
Company Profile
BioTelemetry, Inc. provides monitoring services and digital population health management in a healthcare setting, medical device manufacturing and centralized core laboratory services for clinical research. The company also develops proprietary integrated patient management platform that incorporates wireless data transmission network. It operates through operates through three segments: Healthcare, Technology, and Research. The Healthcare segment focuses on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. The Technology segment engages in the development, manufacturing, testing, and marketing of medical devices to medical companies, clinics, and hospitals. The Research segment engages in the central core laboratory services that provides cardiac monitoring, scientific consulting, and data management services for drug and medical device trials. The company was founded on April 22, 2013 and is headquartered in Malvern, PA.